Navigation Links
Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Date:12/2/2009

ABBOTT PARK, Ill., Dec. 2 /PRNewswire-FirstCall/ -- Abbott's Ibis technology for detecting and characterizing a vast array of microorganisms has been named one of the top innovations in 2009 by The Scientist magazine. A panel of expert judges evaluated a broad range of life science technologies to determine the year's top innovations, with the winners unveiled in the publication's December issue and online at www.the-scientist.com/top10innovations.

"The Scientist is really happy to present our innovation awards for the second time," said Alison McCook, deputy editor. "This year's list captures a wide range of products, from imaging and genomics to other tools that stunningly capture both intracellular and extracellular processes. We look forward to seeing how these products will impact the life sciences."

Abbott's Ibis system (now marketed under the PLEX ID trade name) was recognized for the honor, in part, because it is designed to detect and characterize a broad range of microorganisms in a given sample, including viruses, bacteria and fungi.

"Science is the foundation for everything we do at Abbott, and we're proud to be honored for the distinguished work that our scientists and engineers do to provide important advances across the spectrum of care," said Edward Michael, executive vice president, Diagnostics, Abbott.

Earlier this year, the Ibis technology was named overall Gold winner of the 2009 Wall Street Journal Technology Innovation Awards.

The PLEX ID is a high-throughput system based on a combination of technologies including polymerase chain reaction (PCR) and mass spectrometry analysis.

The system is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as often required with current culturing methods.

PLEX ID is currently not intended for use in diagnostic procedures. Commercial applications for the system include tests developed for use in unregulated areas such as epidemiologic surveillance, biological research, environmental testing, and forensic research.

About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
9. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
10. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
11. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- FinancialBuzz.com News Commentary  ... Based on New Frontier Data,s sales forecasts in ... legal will generate $655 million in taxes on retail sales. Out ... such as Washington State,s 37% cannabis retail ... sales taxes that are applied on all retail sales. By 2020, ...
(Date:3/27/2017)... INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: ... to announce it has received conditional approval to list ... Exchange.  Receiving the conditional listing approval ... for Invictus-MD. Some of which include: ... ("AB Labs"), a Licensed Producer under the Access to ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... management program at Women’s Excellence will help patients lose weight and keep it ... The specialists at Women's Excellence will measure BMI, body fat composition, and ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
(Date:3/26/2017)... Columbus, Ohio (PRWEB) , ... March 26, 2017 ... ... 100 doctors worldwide to receive the RealSelf 100 Award, a prestigious award honoring ... elective cosmetic procedures and to find and connect with doctors and clinics. , ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
Breaking Medicine News(10 mins):